|
 |
| 1-4
September, 2006 Pragati Maidan, New Delhi, India |
 |
|
|
Bid Good ‘Bi’ocon to Diabetes
Bio- insulin launched.
Last week, the Banglore- based biotechnology major Biocon launched its much awaited bio- insulin for the treatment of diabetes, insugen.
Biocon CMD Kiran Mazumdar- Shaw was quoted saying that this very elegant technology, which is developed in house, is India’s most validated insulin. She also claimed that it was the world’s first recombinant human insulin using a Pichia expression vector, a yeast expression system that secretes pre- insulin with very low level of impurities.
This Pichia expression, which can be used for making anything from beer to bread, is licensed from the RCT, USA.
Biocon is looking at the global market for the sale of it's new product and has already submitted a Drug Master File to the USFDA.
Date: 17-Nov-2004
Back
|
|
 |
|
|
|
 |
